Last $14.67 USD
Change Today -0.11 / -0.74%
Volume 65.2K
VCYT On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bonnie H. Anderson

Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee, Veracyte, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 1 different organizations across 1 different industries.

See Board Relationships
56$855,935
As of Fiscal Year 2013

Background*

Ms. Bonnie H. Anderson Co-founded Veracyte, Inc., in 2008 and has been its Chief Executive Officer since February 2008. Ms. Anderson has been President of Veracyte, Inc., since August 2013. She has over 25 years of experience in venture capital consulting and market development services. She served as Vice President-Director of the intrapreneurial Immunomics Operations at Beckman Coulter. Ms. Anderson serves on the Board of Keck Graduate Institute of Life Sciences and ...

Read Full Background

Corporate Headquarters*

7000 Shoreline Court
South San Francisco, California 94080

United States

Phone: 650-243-6300
Fax: 650-243-6301

Board Members Memberships*

2008-Present
Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee

Education*

BS
Indiana University, Bloomington

Other Affiliations*

Annual Compensation*

Salary$380,000
Total Annual Compensation$380,000

Stock Options*

Exercisable Options456,922
Total Number of Options456,922

Total Compensation*

Total Annual Cash Compensation$550,000
Total Short Term Compensation$380,000
Total Calculated Compensation$855,935
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VCYT:US $14.67 USD -0.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
--
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Antonius P. Schuh Ph.D.Chief Executive Officer and Director
TrovaGene, Inc.
$533.1K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERACYTE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.